Upper Respiratory Infection Clinical Trial
Official title:
A Pilot Evaluation of Two Dosing Schedules of American Ginseng Extract in Pediatric Upper Respiratory Tract Infection.
This is a randomized double-blind three-arm trial to evaluate two dosages of CVT-E002 against placebo in pediatric upper respiratory tract infections (URTI). It is hypothesized that CVT-E002 use at standard doses reduces the duration of URTI in children aged 3-12 years.
The eligible children, for whom parental consent has been obtained, will be randomized to one of three groups (standard dose, low dose, or placebo). The standard dose group will receive an oral aqueous solution using the standard dose of CVT-E002, adjusted according to the child's weight. The second group will receive an oral aqueous solution with half of the standard dose of CVT-E002, adjusted according to the child's weight, and the third group will receive a placebo as an aqueous solution of starch that does not contain any CVT-E002 or active medication, volume adjusted for the child's weight. Parents will be provided with a 3-day supply of study medication according to the randomization schedule. CVT-E002 will be administered by the parent to the child three times daily for three consecutive days following the onset of a URTI. Severity and duration of URTI will be measured using the reliable and valid Canadian Acute Respiratory Infection Flu Score (CARIFS). ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03711292 -
Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
|
N/A | |
| Completed |
NCT01168778 -
Improving Communication During Pediatric Visits for Acute Respiratory Illness
|
N/A | |
| Terminated |
NCT00187785 -
Doctor-Patient Communication in Spanish
|
N/A | |
| Completed |
NCT00405509 -
The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years
|
N/A | |
| Completed |
NCT00189475 -
Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds
|
Phase 4 | |
| Completed |
NCT04468204 -
Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)
|
N/A | |
| Active, not recruiting |
NCT05666752 -
Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
|
N/A | |
| Suspended |
NCT05035420 -
A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
|
N/A | |
| Recruiting |
NCT06244615 -
Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat
|
N/A | |
| Completed |
NCT02694679 -
Randomized Controlled Trial of Social Network Targeting in Honduras
|
N/A | |
| Completed |
NCT05352581 -
BD Veritor™ At-Home and BD Veritor™ Professional
|
||
| Active, not recruiting |
NCT02943551 -
Dialogue Around Respiratory Illness Treatment
|
N/A | |
| Completed |
NCT02110732 -
Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
|
N/A | |
| Completed |
NCT01657643 -
Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections
|
N/A | |
| Completed |
NCT00694421 -
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
|
N/A | |
| Completed |
NCT03884777 -
Incidence and Risk of Influenza in Myasthenic Patients
|
||
| Completed |
NCT00796315 -
Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
|
Phase 1 | |
| Completed |
NCT00642681 -
Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
|
Phase 2 | |
| Completed |
NCT00259831 -
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
|
Phase 3 | |
| Completed |
NCT04588376 -
Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison
|
N/A |